181 related articles for article (PubMed ID: 36410810)
1. Seroprevalence of SARS-CoV-2 antibodies among Forcibly Displaced Myanmar Nationals in Cox's Bazar, Bangladesh 2020: a population-based cross-sectional study.
Rahman M; Khan SR; Alamgir ASM; Kennedy DS; Hakim F; Evers ES; Afreen N; Alam AN; Islam MS; Paul D; Bhuiyan R; Islam R; Moureen A; Salimuzzaman M; Billah MM; Sharif AR; Akter MK; Sultana S; Khan MH; von Harbou K; Zaman MM; Shirin T; Flora MS
BMJ Open; 2022 Nov; 12(11):e066653. PubMed ID: 36410810
[TBL] [Abstract][Full Text] [Related]
2. Misconceptions about COVID-19 among older Rohingya (forcefully displaced Myanmar nationals) adults in Bangladesh: findings from a cross-sectional study.
Mistry SK; Ali ARMM; Yadav UN; Ghimire S; Hossain MB; Saha M; Reza S; Bakshi P; Bhuiyan ATMRH; Harris M
BMJ Open; 2021 May; 11(5):e050427. PubMed ID: 34049923
[TBL] [Abstract][Full Text] [Related]
3. Oral cholera vaccine coverage evaluation survey: Forcibly Displaced Myanmar Nationals and host community in Cox's Bazar, Bangladesh.
Qayum MO; Billah MM; Sarker MFR; Alamgir ASM; Nurunnahar M; Khan MH; Salim Uzzaman M; Henderson A; Shirin T; Flora MS
Front Public Health; 2023; 11():1147563. PubMed ID: 37475769
[TBL] [Abstract][Full Text] [Related]
4. Difficulties faced by older Rohingya (forcibly displaced Myanmar nationals) adults in accessing medical services amid the COVID-19 pandemic in Bangladesh.
Mistry SK; Ali AM; Yadav UN; Huda MN; Ghimire S; Bestman A; Hossain MB; Reza S; Qasim R; Harris MF
BMJ Glob Health; 2021 Dec; 6(12):. PubMed ID: 34903566
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of a killed bivalent whole cell oral cholera vaccine in forcibly displaced Myanmar nationals in Cox's Bazar, Bangladesh.
Chowdhury F; Bhuiyan TR; Akter A; Bhuiyan MS; Khan AI; Hossain M; Tauheed I; Ahmed T; Islam S; Rafique TA; Siddique SA; Harun NB; Islam K; Clemens JD; Qadri F
PLoS Negl Trop Dis; 2020 Mar; 14(3):e0007989. PubMed ID: 32176695
[TBL] [Abstract][Full Text] [Related]
6. Are older adults of Rohingya community (Forcibly Displaced Myanmar Nationals or FDMNs) in Bangladesh fearful of COVID-19? Findings from a cross-sectional study.
Mistry SK; Ali ARMM; Akther F; Peprah P; Reza S; Prova S; Yadav UN
PLoS One; 2021; 16(6):e0253648. PubMed ID: 34161389
[TBL] [Abstract][Full Text] [Related]
7. Screening for malaria antigen and anti-malarial IgG antibody in forcibly-displaced Myanmar nationals: Cox's Bazar district, Bangladesh, 2018.
Lu A; Cote O; Dimitrova SD; Cooley G; Alamgir A; Uzzaman MS; Flora MS; Widiati Y; Akhtar MS; Vandenent M; Ehlman DC; Bennett SD; Feldstein LR; Rogier E
Malar J; 2020 Mar; 19(1):130. PubMed ID: 32228699
[TBL] [Abstract][Full Text] [Related]
8. Cholera outbreak in Forcibly Displaced Myanmar National (FDMN) from a small population segment in Cox's Bazar, Bangladesh, 2019.
Faruque ASG; Khan AI; Nahar B; Islam SMR; Hossain MN; Abdullah SA; Khan SH; Hossain MS; Khan FH; Prajapati M; Widiati Y; Hasan ASMM; Kim M; Musto J; Vandenent M; Clemens JD; Ahmed T
PLoS Negl Trop Dis; 2021 Sep; 15(9):e0009618. PubMed ID: 34550972
[TBL] [Abstract][Full Text] [Related]
9. Acute Watery Diarrhea Surveillance During the Rohingya Crisis 2017-2019 in Cox's Bazar, Bangladesh.
Islam MT; Khan AI; Khan ZH; Tanvir NA; Ahmmed F; Afrad MMH; Begum YA; Kim M; Hasan ASMM; Vandenent M; Uzzaman MS; Shirin T; Clemens JD; Qadri F
J Infect Dis; 2021 Dec; 224(12 Suppl 2):S717-S724. PubMed ID: 34528689
[TBL] [Abstract][Full Text] [Related]
10. Bacterial and viral etiology of acute respiratory infection among the Forcibly Displaced Myanmar Nationals (FDMNs) in fragile settings in Cox's Bazar- a prospective case-control study.
Siddik AB; Tanvir NA; Bhuyan GS; Alam MS; Islam Z; Bulbul MRH; Moniruzzaman M; Halder CE; Rahman T; Endtz H; Ahmed S; Qadri F; Picot VS
PLoS Negl Trop Dis; 2023 Apr; 17(4):e0011189. PubMed ID: 37036845
[TBL] [Abstract][Full Text] [Related]
11. The assessment of geriatric malnutrition, geriatric depression and associated co-morbidities among forcibly displaced Myanmar nationals in Bangladesh.
Alam MM; Das R; Clara AA; Mohsin FM; Rumi MAH; Wahab A; Hasan MA; Hawlader MDH
Public Health Nutr; 2023 Oct; 26(10):2048-2055. PubMed ID: 37529859
[TBL] [Abstract][Full Text] [Related]
12. Vaccination coverage survey and seroprevalence among forcibly displaced Rohingya children, Cox's Bazar, Bangladesh, 2018: A cross-sectional study.
Feldstein LR; Bennett SD; Estivariz CF; Cooley GM; Weil L; Billah MM; Uzzaman MS; Bohara R; Vandenent M; Adhikari JM; Leidman E; Hasan M; Akhtar S; Hasman A; Conklin L; Ehlman D; Alamgir A; Flora MS
PLoS Med; 2020 Mar; 17(3):e1003071. PubMed ID: 32231368
[TBL] [Abstract][Full Text] [Related]
13. Seroprevalence of SARS-CoV-2 antibodies and associated risk factors in children less than 6 years of age in the canton of Fribourg, Switzerland (COVPED study): a population-based cross-sectional study.
Rouge Elton PA; Schmitt PA; Faouzi M; Zimmermann P; Ritter Schenk C
Swiss Med Wkly; 2022 May; 152():w30173. PubMed ID: 35748747
[TBL] [Abstract][Full Text] [Related]
14. Diarrhea treatment center (DTC) based diarrheal disease surveillance in settlements in the wake of the mass influx of forcibly displaced Myanmar national (FDMN) in Cox's Bazar, Bangladesh, 2018.
Faruque ASG; Khan AI; Islam SMR; Nahar B; Hossain MN; Widiati Y; Hasan ASMM; Prajapati M; Kim M; Vandenent M; Ahmed T
PLoS One; 2021; 16(8):e0254473. PubMed ID: 34339419
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 antibody seroprevalence in India, August-September, 2020: findings from the second nationwide household serosurvey.
Murhekar MV; Bhatnagar T; Selvaraju S; Saravanakumar V; Thangaraj JWV; Shah N; Kumar MS; Rade K; Sabarinathan R; Asthana S; Balachandar R; Bangar SD; Bansal AK; Bhat J; Chopra V; Das D; Deb AK; Devi KR; Dwivedi GR; Khan SMS; Kumar CPG; Kumar MS; Laxmaiah A; Madhukar M; Mahapatra A; Mohanty SS; Rangaraju C; Turuk A; Baradwaj DK; Chahal AS; Debnath F; Haq I; Kalliath A; Kanungo S; Kshatri JS; Lakshmi GGJN; Mitra A; Nirmala AR; Prasad GV; Qurieshi MA; Sahay S; Sangwan RK; Sekar K; Shukla VK; Singh PK; Singh P; Singh R; Varma DS; Viramgami A; Panda S; Reddy DCS; Bhargava B;
Lancet Glob Health; 2021 Mar; 9(3):e257-e266. PubMed ID: 33515512
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study.
Poustchi H; Darvishian M; Mohammadi Z; Shayanrad A; Delavari A; Bahadorimonfared A; Eslami S; Javanmard SH; Shakiba E; Somi MH; Emami A; Saki N; Hormati A; Ansari-Moghaddam A; Saeedi M; Ghasemi-Kebria F; Mohebbi I; Mansour-Ghanaei F; Karami M; Sharifi H; Pourfarzi F; Veisi N; Ghadimi R; Eghtesad S; Niavarani A; Ali Asgari A; Sadeghi A; Sorouri M; Anushiravani A; Amani M; Kaveh S; Feizesani A; Tabarsi P; Keyvani H; Markarian M; Shafighian F; Sima A; Sadjadi A; Radmard AR; Mokdad AH; Sharafkhah M; Malekzadeh R
Lancet Infect Dis; 2021 Apr; 21(4):473-481. PubMed ID: 33338441
[TBL] [Abstract][Full Text] [Related]
17. Seroprevalence of SARS-CoV-2-specific anti-spike IgM, IgG, and anti-nucleocapsid IgG antibodies during the second wave of the pandemic: A population-based cross-sectional survey across Kashmir, India.
Lone KS; Khan SMS; Qurieshi MA; Majid S; Pandit MI; Haq I; Ahmad J; Bhat AA; Bashir K; Bilquees S; Fazili AB; Hassan M; Jan Y; Kaul RR; Khan ZA; Mushtaq B; Nazir F; Qureshi UA; Raja MW; Rasool M; Asma A; Bhat AA; Chowdri IN; Ismail S; Jeelani A; Kawoosa MF; Khan MA; Khan MS; Kousar R; Lone AA; Nabi S; Qazi TB; Rather RH; Sabah I; Sumji IA
Front Public Health; 2022; 10():967447. PubMed ID: 36276377
[TBL] [Abstract][Full Text] [Related]
18. Health problems among Forcibly Displaced Myanmar Nationals (FDMNs) admitted to the Medicine ward of Cox's Bazar Medical College Hospital.
Ismail M; Hussain MF; Abdullah Al Hasan M; Kamal AM; Rahman M; Hasan MJ
J Migr Health; 2022; 6():100123. PubMed ID: 35694421
[TBL] [Abstract][Full Text] [Related]
19. Seroprevalence of anti-SARS-CoV-2 antibodies after the first wave of the COVID-19 pandemic in a vulnerable population in France: a cross-sectional study.
Beaumont A; Durand C; Ledrans M; Schwoebel V; Noel H; Le Strat Y; Diulius D; Colombain L; Médus M; Gueudet P; Mouly D; Aumaître H
BMJ Open; 2021 Nov; 11(11):e053201. PubMed ID: 34815286
[TBL] [Abstract][Full Text] [Related]
20. Sero-prevalence and risk factors for Severe Acute Respiratory Syndrome Coronavirus 2 infection in women and children in a rural district of Bangladesh: A cohort study.
Khanam R; Islam S; Rahman S; Ahmed S; Islam A; Hasan T; Hasan E; Chowdhury NH; Roy AD; Jaben IA; Nehal AA; Yoshida S; Manu AA; Raqib R; McCollum ED; Shahidullah M; Jehan F; Sazawal S; Bahl R; Baqui AH
J Glob Health; 2022 Jul; 12():05030. PubMed ID: 35866222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
